WASHINGTON (Reuters) - Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health Solutions are accumulating as U.S. antitrust regulators weigh whether they have enough evidence to stop the megamerger.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/B_nLOKF9je8/us-medco-expressscripts-antitrust-idUSTRE8151UD20120206
recent news save money travel make money best news online money
No comments:
Post a Comment